Skip to content Skip to footer

Merz Expert Connect 2023 video

This is protected content to be accessed by healthcare professionals only.

The symposium was opened by Gerard Francisco who provided a history of Toxnet, its mission and achievements to date. He presented some research, recently undertaken by the group, that identified and ranked key barriers to accessing quality, evidenced-based post-stroke spasticity management.

Dr Jorge Jacinto introduced the new GO-FAST tool1 that has been developed to meeting one of the key educational needs identified in the research.

Finally, Dr Stefano Carda led a highly interactive session, highlighting the utility of the GO-FAST tool, to identify and select appropriate goals for a complex post-stroke spasticity patient case.

Tap the Chapters icon in the video playback panel for a menu to access a chapter directly.

Chapter 1: A history of Toxnet, mission and achievements to date (Professor Gerard Francisco) [beginning to 12:53]
Chapter 2: An introduction to the GO-FAST tool (Dr Jorge Jacinto) [12:53 – 25:23]
Chapter 3: An interactive presentation of the GO-FAST tool in clinical use (Dr Stefano Carda) [25:23 – 45:16]

Supported by Merz Therapeutics GmbH

Liability for links
Our site contains links to external websites, over which we have no control. Therefore we cannot accept any responsibility for this external content. The respective provider or operator is always responsible for the contents of any linked site. At the time of linking the linked sites where checked for possible legal violations. At the time of linking illegal contents were not indicated. A permanent control of the linked pages is unreasonable without concrete evidence of violation. Upon notification of violations, we will remove such links immediately.

Award scoring criteria

The following criteria will be judged out of a score of 5; (1 is suboptimal; 2 is adequate; 3 is good; 4 is very good; 5 is excellent)

GENERAL

  • Days per week working in spasticity management
  • Average number of spasticity patients managed per month
  • Environment and clinical team (type of institution, location, size/structure of clinical team, particular patient needs)
  • Role of responsibility in managing patients with spasticity
  • Scientific appointments in spasticity
  • Honours for work undertaken in spasticity

SCHOLARLY

  • Number of research projects investigating relevant aspects of spasticity management
  • Impact of research projects investigating relevant aspects of spasticity management
  • Number of peer-reviewed publications on topic
    Number of presentations of research at international meetings
  • Number of presentations at national conferences
  • Teaching/mentorship of younger injectors
  • h-index

CLINICAL

  • Evidence of development or growth of a spasticity program at the applicant’s practice or institution
  • Breadth of services provided, including medications, toxins, physical interventions, and Intrathecal Baclofen Therapy (ITB)
  • Role of responsibility in managing patients with spasticity

ENDORSEMENT

  • Endorsed by senior peer

In the event of a tie, based on the above scoring criteria, the Toxnet Co-Chairs will make the final decision.